Dietary α-mangostin, a xanthone from mangosteen fruit, exacerbates experimental colitis and promotes dysbiosis in mice

Molecular Nutrition and Food Research

Volumn 58, Issue 6, 2014, Pages 1226-1238

  Gutierrez Orozco, Fabiola ^a   Thomas Ahner, Jennifer M ^a,b   Berman Booty, Lisa D ^a,c,e   Galley, Jeffrey D ^a   Chitchumroonchokchai, Chureeporn ^a   Mace, Thomas ^a,b   Suksamrarn, Sunit ^d   Bailey, Michael T ^a   Clinton, Steven K ^a,b,c   Lesinski, Gregory B ^a,c   Failla, Mark L ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d SRINAKHARINWIROT UNIVERSITY   (Thailand)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Diet; Gut microbiota; Inflammation; Mouse model

Indexed keywords

AMYLOID; DEXTRAN SULFATE; INTERLEUKIN 6; MANGOSTIN; PEROXIDASE; XANTHONE DERIVATIVE;

ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; CHEMISTRY; COLON; DIET; DIET SUPPLEMENTATION; DISEASE MODEL; DRUG EFFECTS; DYSBIOSIS; ENZYMOLOGY; FEMALE; FRUIT; GARCINIA MANGOSTANA; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MOUSE; PATHOLOGY; PROTEOBACTERIA; ULCERATIVE COLITIS;

AMYLOID; ANIMALS; COLITIS, ULCERATIVE; COLON; DEXTRAN SULFATE; DIET; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DYSBIOSIS; FEMALE; FRUIT; GARCINIA MANGOSTANA; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; PEROXIDASE; PROTEOBACTERIA; XANTHONES;

EID: 84901947811     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300771     Document Type: Article

References (59)

1. Khor, B., Gardet, A., Xavier, R. J., Genetics and pathogenesis of inflammatory bowel disease. Nature 2011, 474, 307-317.
2. Clapper, M. L., Cooper, H. S., Chang, W. C., Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol. Sin. 2007, 28, 1450-1459.
3. Ordás, I., Eckmann, L., Talamini, M., Baumgart, D. C. et al., Ulcerative colitis. Lancet 2012, 380, 1606-1619.
4. Tamboli, C. P., Neut, C., Desreumaux, P., Colombel, J. F., Dysbiosis in inflammatory bowel disease. Gut 2004, 53, 1-4.
5. Melgar, S., Karlsson, A., Michaëlsson, E., Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am. J. Gastrointest. Liver Physiol. 2005, 288, G1328-G1338.
6. Lanzoni, G., Roda, G., Belluzzi, A., Roda, E. et al., Inflammatory bowel disease: moving toward a stem cell-based therapy. World J. Gastroenterol. 2008, 14, 4616-4626.
7. Rahimi, R., Mozaffari, S., Abdollahi, M., On the use of herbal medicines in management of inflammatory bowel diseases: a systematic review of animal and human studies. Dig. Dis. Sci. 2009, 54, 471-480.
8. Wu, X., Schauss, A. G., Mitigation of inflammation with foods. J. Agric. Food Chem. 2012, 60, 6703-6717.
9. Pan, M. H., Lai, C. S., Ho, C. T., Anti-inflammatory activity of natural dietary flavonoids. Food Funct. 2010, 1, 15-31.
10. Pedraza-Chaverri, J., Cárdenas-Rodríguez, N., Orozco-Ibarra, M., Pérez-Rojas, J. M., Medicinal properties of mangosteen (Garcinia mangostana). Food Chem. Toxicol. 2008, 46, 3227-3239.
11. Walker, E. B., HPLC analysis of selected xanthones in mangosteen fruit. J. Sep. Sci. 2007, 30, 1229-1234.
12. Gutierrez-Orozco, F., Chitchumroonchokchai, C., Lesinski, G. B., Suksamrarn, S. et al., α-Mangostin: anti-Inflammatory activity and metabolism by human cells. J. Agric. Food Chem. 2013, 61, 3891-3900.
13. Bumrungpert, A., Kalpravidh, R. W., Chuang, C. C., Overman, A. et al., Xanthones from mangosteen inhibit inflammation in human macrophages and in human adipocytes exposed to macrophage-conditioned media. J. Nutr. 2010, 140, 842-847.
14. Chen, L. G., Yang, L. L., Wang, C. C., Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem. Toxicol. 2008, 46, 688-693.
15. Jang, H. Y., Kwon, O. K., Oh, S. R., Lee, H. K. et al., Mangosteen xanthones mitigate ovalbumin-induced airway inflammation in a mouse model of asthma. Food Chem. Toxicol. 2012, 50, 4042-4050.
16. Tang, Y. P., Li, P. G., Kondo, M., Ji, H. P. et al., Effect of a mangosteen dietary supplement on human immune function: a randomized, double-blind, placebo-controlled trial. J. Med. Food 2009, 12, 755-763.
17. Sloan, E. W., Getting ahead of the curve: phytochemicals. Nutraceutical World 2010, 13, 16-17.
18. Chitchumroonchokchai, C., Thomas-Ahner, J. M., Li, J., Riedl, K. M. et al., Anti-tumorigenicity of dietary α-mangostin in an HT-29 colon cell xenograft model and the tissue distribution of xanthones and their phase II metabolites. Mol. Nutr. Food Res. 2013, 57, 203-211.
19. Chaivisuthangkura, A., Malaikaew, Y., Chaovanalikit, A., Jaratrungtawee, A., Prenylated xanthone composition of Garcinia mangostana (mangosteen) fruit hull. Chromatographia 2009, 69, 315-318.
20. Reagan-Shaw, S., Nihal, M., Ahmad, N., Dose translation from animal to human studies revisited. FASEB J. 2008, 22, 659-661.
21. Johnson, J. J., Petiwala, S., Syed, D., Rasmussen, J. et al., α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth. Carcinogenesis 2012, 33, 413-419.
22. Chitchumroonchokchai, C., Riedl, K. M., Suksumrarn, S., Clinton, S. K. et al., Xanthones in mangosteen juice are absorbed and partially conjugated by healthy adults. J. Nutr. 2012, 142, 675-680.
23. Ding, S., Walton, K., Blue, R., McNaughton, K. et al., Mucosal healing and fibrosis after acute or chronic inflammation in wild type FVB-N mice and C57BL6 procollagen α1(I)-promoter-GFP reporter mice. PLoS One 2012, 7, e42568.
24. Murthy, S. N., Cooper, H. S., Shim, H., Shah, R. S. et al., Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig. Dis. Sci. 1993, 38, 1722-1734.
25. Cooper, H. S., Murthy, S. N., Shah, R. S., Sedergran, D. J., Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 1993, 69, 238-249.
26. Mähler, M., Bristol, I., Leiter, E., Workman, A. et al., Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am. J. Physiol. 1998, 274, G544-G551.
27. Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K. et al., QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 2010, 7, 335-336.
28. Edgar, R. C., Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010, 26, 2460-2461.
29. Wang, Q., Garrity, G. M., Tiedje, J. M., Cole, J. R., Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 2007, 73, 5261-5267.
30. McDonald, D., Price, M., Goodrich, J., Nawrocki, E. et al., An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012, 6, 610-618.
31. Caporaso, J. G., Bittinger, K., Bushman, F. D., DeSantis, T. Z. et al., PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics 2010, 26, 266-267.
32. Lozupone, C., Knight, R., UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 2005, 71, 8228-8235.
33. Ramirez-Carrozzi, V., Sambandam, A., Luis, E., Lin, Z. et al., IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat. Immunol. 2011, 12, 1159-1166.
34. Sund, M., Xu, L. L., Rahman, A., Qian, B. F. et al., Reduced susceptibility to dextran sulphate sodium-induced colitis in the interleukin-2 heterozygous (IL-2) mouse. Immunology 2005, 114, 554-564.
35. -AR) on colonic motility or progression of colitis in the mouse. Inflamm. Bowel Dis. 2011, 17, 1698-1713.
36. Alex, P., Zachos, N., Nguyen, T., Gonzales, L. et al., Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm. Bowel Dis. 2009, 15, 341-352.
37. Barnes, P. M., Bloom, B., Nahin, R., Complementary and alternative medicine use among adults and children: United States, 2007. National health statistics reports, no. 12, National Center for Health Statistics 2008, Hyattsville, MD, USA.
38. Gutierrez-Orozco, F., Failla, M. L., Biological activities and bioavailability of mangosteen xanthones: a critical review of the current evidence. Nutrients 2013, 5, 3163-3183.
39. Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C. et al., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 2007, 104, 13780-13785.
40. EGFP mice. PLoS One 2009, 4, e4562.
41. EGFP transgenic mice through blockade of NF-κB-dependent protective molecules. PLoS One 2007, 2, e596.
42. Kim, M., Murakami, A., Miyamoto, S., Tanaka, T. et al., The modifying effects of green tea polyphenols on acute colitis and inflammation-associated colon carcinogenesis in male ICR mice. Biofactors 2010, 36, 43-51.
43. Yapwattanaphun, C., Subhadrabandhu, S., Sugiura, A., Yonemori, K. et al., Utilization of some Garcinia species in Thailand. Acta Hort. 2002, 575, 563-570.
44. Walker, N., Bennett, T., Axelsen, R. A., Melanosis coli. A consequence of antraquinone-induced apoptosis of colonic epithelial cells. Am. J. Path. 1988, 131, 465-476.
45. Chin, Y., Kinghorn, A. D., Structural characterization, biological effects, and synthetic studies on xanthones from mangosteen (Garcinia mangostana), a popular botanical dietary supplement. Mini-Rev. Org. Chem. 2008, 5, 355-364.
46. Sindermusk, J., Deekijsermphong, S., The antibacterial activities of crude extract from the fruit hull of Garcinia mangostana on enteric pathogens and intestinal commensal flora. Bull. Depart. Med. Services 1989, 14, 421-426.
47. Eckburg, P. B., Bik, E., Bernstein, C., Purdom, E. et al., Diversity of the human intestinal microbial flora. Science 2005, 308, 1635-1638.
48. Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A. et al., Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. 2005, 102, 11070-11075.
49. Lupp, C., Robertson, M., Wickham, M., Sekirov, I. et al., Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007, 2, 119-129.
50. Ott, S. J., Musfeldt, M., Wenderoth, D., Hampe, J. et al., Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004, 53, 685-693.
51. Maslowski, K. M., Vieira, A., Ng, A., Kranich, J. et al., Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461, 1282-1286.
52. Macfarlane, S., Macfarlane, G. T., Regulation of short-chain fatty acid production. Proc. Nutr. Soc. 2003, 62, 67-72.
53. Christensen, H. R., Frøkiaer, H., Pestka, J. J., Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 2002, 168, 171-178.
54. Fite, A., Macfarlane, S., Furrie, E., Bahrami, B. et al., Longitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and duration. J. Clin. Microbiol. 2013, 51, 849-856.
55. Pathmakanthan, S., Thornley, J. P., Hawkey, C. J., Mucosally associated bacterial flora of the human colon: quantitative and species specific differences between normal and inflamed colonic biopsies. Microb. Ecol. Health Dis. 1999, 11, 169-174.
56. Heimesaat, M. M., Fischer, A., Siegmund, B., Kupz, A. et al., Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One 2007, 2, e662.
57. Campbell, J., Foster, C., Vishnivetskaya, T., Campbell, A. et al., Host genetic and environmental effects on mouse intestinal microbiota. ISME J. 2012, 6, 2033-2044.
58. Kitajima, S., Morimoto, M., Sagara, E., Shimizu, C. et al., Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. Exp. Anim. 2001, 50, 387-395.
59. Siow, R., Mann, G. E., Dietary isoflavones and vascular protection: activation of cellular antioxidant defenses by SERMs or hormesis? Mol. Aspects Med. 2010, 31, 468-477.